-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Friday's After-Market Session
Share
Listen to the news

Gainers

  • Pomdoctor (NASDAQ:POM) shares rose 25.6% to $1.47 during Friday's after-market session. The market value of their outstanding shares is at $8.3 million.
  • GeneDx Holdings (NASDAQ:WGS) shares rose 8.72% to $61.05. The company's market cap stands at $2.0 billion.
  • Phio Pharmaceuticals (NASDAQ:PHIO) stock moved upwards by 7.65% to $0.92. The company's market cap stands at $10.3 million.
  • SciSparc (NASDAQ:SPRC) shares moved upwards by 6.48% to $1.15.
  • Neumora Therapeutics (NASDAQ:NMRA) stock increased by 5.69% to $0.4. The market value of their outstanding shares is at $78.1 million.
  • Kala Bio (NASDAQ:KALA) stock rose 5.42% to $0.2. The market value of their outstanding shares is at $3.6 million.

Losers

  • Cumberland Pharma (NASDAQ:CPIX) shares fell 10.6% to $7.59 during Friday's after-market session. The company's market cap stands at $122.4 million.
  • Silexion Therapeutics (NASDAQ:SLXN) shares declined by 10.21% to $0.17. The company's market cap stands at $2.3 million.
  • CytoSorbents (NASDAQ:CTSO) shares decreased by 8.73% to $4.81. The market value of their outstanding shares is at $16.8 million.
  • Karyopharm Therapeutics (NASDAQ:KPTI) stock declined by 8.1% to $0.48. The company's market cap stands at $9.6 million.
  • Orchestra BioMed Hldgs (NASDAQ:OBIO) stock fell 6.45% to $5.23. The market value of their outstanding shares is at $348.9 million.
  • Radiopharm Theranostics (NASDAQ:RADX) stock decreased by 6.09% to $0.95. The company's market cap stands at $14.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending